Fulgent Genetics (FLGT) revenue breakdown
By region, United States is the largest at 92% of fiscal 2025 revenue, growing 55% a year over 8 years.
Revenue by region
Fiscal years, as Fulgent Genetics reports them in its 10-K filings; fiscal 2025 total $323M.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $9M | $13M | $25M | $415M | $979M | $603M | $269M | $259M | $297M | 92% |
| Other countries | — | — | — | — | — | $7M | $9M | $12M | $13M | 4% |
| China | — | — | — | — | — | $9M | $11M | $13M | $13M | 4% |
| Foreign | — | — | $8M | $6M | $14M | — | — | — | — | — |
| Other Countries | $3M | $5M | — | — | — | — | — | — | — | — |
| Canada | $4M | $4M | — | — | — | — | — | — | — | — |
| People's Republic of China ("PRC") | $3M | — | — | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for FLGT.
Open FLGT in InvestinglyQuestions
Where does Fulgent Genetics make its money?
In fiscal 2025, by region: United States $297M, Other countries $13M, China $13M.
From Fulgent Genetics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.